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“...in the second decade of the Asian Century it is perhaps befitting that a material of so 
much importance to the continent’s cultural and economic history, should become the 
focus of cutting-edge biomedical research.” 
 
 
Hardly a month goes by within the scientific literature without some new material “X” being 
reported as a suitable material on which to grow cell type “Y”, for the potential purpose of 
treating disease “Z”. Thus when fibroin, a protein found in silk, was first proposed as a 
biomaterial for cell growth [1] it joined a long list of other materials of both natural as well as 
synthetic origin. Nevertheless, in the second decade of the Asian Century it is perhaps 
befitting that a material of so much importance to the continent’s cultural and economic 
history, should become the focus of cutting-edge biomedical research. Sentiments aside, 
however, silk fibroin possesses quite a unique combination of properties which make it a 
promising candidate for repairing the eye and especially for treating damage to the cornea, the 
transparent window at the front of the eye. 
Silks belong to the group of fibrous proteins, known also as ‘structural’ or ‘fibrillar’ 
proteins, which also includes collagens, elastins, keratins, and myosins. Specifically, the silk 
proteins contain highly repetitive sequences of amino acids and are stored in the organism as 
liquids before being configured into fibres when sheared/spun upon extrusion from the 
organism for the purpose of generating webs or cocoons. In nature, the silks are produced 
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solely by species of the phylum Arthropoda, and only by organisms in classes Arachnida and 
Insecta, and subphylum Myriapoda. Although variable in composition and structure, the silks 
serve the same purposes for all these organisms, i.e. protection, structural support, assistance 
in reproduction and foraging. By far, the most investigated silk is that produced by the 
domesticated silkworm, the larva of the Bombyx mori silkmoth. As part of the reproductive 
cycle, the larvae generate cocoons that are made of silk threads and constitute the 
predominant source for both the textile industry and research community. A silk thread is 
organized hierarchically starting from macromolecules of a protein called ‘fibroin’ to 
nanofibrils, then microfibrils and ultimately to brins. The fibroin monofilaments in brins are 
coated and glued together with another protein called ‘sericin’ to generate silk threads. 
Chemically, Bombyx mori silk fibroin (henceforth BMSF) is a composite of evolutionary, 
naturally designed block copolymers. As a protein, its primary structure is dominated by three 
amino acids: glycine, serine and alanine. The BMSF protein composite consists of a heavy-
chain fibroin (~ 390 kDa) linked through covalent disulfide bonds to a light-chain fibroin (~ 
25 kDa), to which a glycoprotein known as protein P25 is associated non-covalently. In the 
insect silk fibroins, a disulfide bond connects 6 molecules of heavy fibroin to 6 molecules of 
light fibroin, while a single molecule of P25 is associated by physical interactions to the 
complex [2,3]. The secondary structure of insect silks involves a mixture of conformations 
including !-helix, parallel and anti-parallel "-pleated sheets, random coil and cross "-pleated 
sheets, but not all of them have been identified in BMSF [4]. The distribution of these 
conformations determines the existence of at least two types of BMSF (known as types I and 
II), and ultimately dictates the evolutionary value of the silk for the organism that generated 
it. BMSF may also posses a tertiary structure due to a combination of extensive hydrogen 
bonding, high crystallinity and predominantly hydrophobic characteristics.   
Silk became a biomaterial long before the latter term was introduced in the scientific 
idiom. Indeed, the silk produced by Bombyx mori has been extensively used to make surgical 
sutures. Owing to sensitizing reactions which are attributed to the presence of sericin, 
currently the latter is removed from the silk sutures. As such, BMSF can be easily isolated 
from sericin and has been proposed as a biomaterial on its own about two decades ago [1]. 
There has been an increasing interest ever since in the use of silks, mainly in the form of 
BMSF, for biomedical applications [5,6]. As a biomaterial, BMSF displays indeed an 
impressive array of favourable properties including high biocompatibility, good mechanical 
properties, and permeability to oxygen and to large molecules. In the living tissues, BMSF 
biodegrades slowly leading to non-toxic residues. It can be processed into a large variety of 
material types (films, membranes, fibres, nets, sponges), at low cost and without the 
involvement of toxic solvents. Finally, and importantly, BMSF can be made into transparent 
materials.     
 
 
“The remarkable transparency of silk fibroin membrane makes this material an obvious 
candidate for use as a biomaterial in corneal reconstruction.” 
 
 
Fibroin membranes are highly transparent sheets of protein formed by allowing thin 
layers of fibroin solution to dry in contact with a flat surface, followed by stabilisation by 
treatment in polar solvents or using water vapour annealing techniques, which generally 
enhance the content of "-sheet conformations. This process can be performed simply in 
standard Petri dishes, but ultra-thin membranes measuring a few microns in thickness can be 
reliably produced to a high degree of accuracy using tape-casting techniques. The remarkable 
transparency of the silk fibroin membranes makes this material an obvious candidate for use 
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as a biomaterial in corneal reconstruction. Moreover, the membranes are sufficiently 
permeable to allow the translocation of nutrients and other factors deemed important for 
establishing and maintaining normal tissue structure and function. Further increases in 
permeability can be achieved by preparation of membranes in the presence of other materials 
such as poly(ethylene) oxide which promote the formation of pores within the membrane. 
These procedures had been well established by others at the time of commencing our studies 
[7], but surprisingly had never been applied for the purpose of growing corneal tissue. 
The feasibility of growing corneal cells on BMSF membranes was first reported by 
our group using primary cultures of corneal epithelial cells grown from human donor eye 
tissue [8, 9]). Subsequent studies by us and others have confirmed that fibroin membranes 
support the growth of cells isolated from all three cellular layers of the cornea including 
stromal cells [10, 11] and corneal endothelial cells [12]. Thus it is conceivable that a full-
thickness, corneal tissue substitute might be generated by combining multiple layers of fibroin 
membrane with appropriate cell types grown on each according to their respective location 
within the cornea (i.e. epithelial layer on top, endothelial layer on the bottom and several 
stromal layers in between). Importantly, primary cultures of corneal epithelial cells grown on 
BMSF retain a similar number of progenitor cells to those observed in cultures grown on 
donor amniotic membrane, the current standard substrate for transplantation of cultured 
corneal epithelial cells [13]. Likewise, the phenotype of corneal stromal cells has been found 
to be unaffected by cultivation on this foreign material [11]. Moreover, preliminary studies of 
biocompatibility in a pre-clinical model have demonstrated that fibroin membranes appear to 
be well tolerated when implanted within the corneal stroma [14]. It must be said, however, 
that similar results to those outlined above have been achieved using other materials including 
modified formulations of collagen [15]. So what benefits, if any, does silk fibroin afford 
above those displayed by collagen and especially more complex and highly utilized materials 
such as amniotic membrane? Ironically, the ultimate benefits of fibroin membrane may be 
that Bombyx mori silk fibroin inherently lacks recognisable cell-binding motifs that are 
normally required for cells to interact with collagen and other extracellular matrix 
components.  
 
 
“In other words, BMSF can be considered to be akin to a blank canvas onto which any 
required combination of materials can be applied in order to elicit the desired response in 
cultured cells.” 
 
 
The absence of apparent cell-binding motifs is an intriguing aspect of cellular 
interactions with fibroin. In the absence of exogenous cell attachment factors such as those 
normally supplied by inclusion of serum in the culture medium, corneal epithelial cells 
generally adhere poorly to BMSF membranes and indeed four-fold fewer cells bind to this 
material than to amniotic membrane under serum-free conditions [13]. BMSF, like culture 
plastic, therefore appears to be relatively inert, with the type and level of cell attachment 
being dependent upon the presence of exogenous materials. For example, improved 
attachment of corneal endothelial cells to silk fibroin has been achieved through coating with 
collagen IV [12]. In other words, BMSF can be considered to be akin to a blank canvas onto 
which any required combination of materials can be applied in order to elicit the appropriate 
cellular response. Such an arrangement is particularly attractive in the case of growing 
cultures from stem cells since their developmental fate is often highly dependent upon the 
surrounding milieu of extracellular materials. By comparison, proteins such as collagens with 
their inherent cell-recognition motifs, present instructions to cells that may or may not be 
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appropriate to a particular cell type. Alternatively, synthetic biomaterials such as those based 
for example on polylactides, are often less amenable to decoration with required exogenous 
cell attachment factors. 
In conclusion, BMSF displays significant potential as a biomaterial for repairing the 
cornea. The transparency of BMSF membranes and their amenability to treatment with cell-
attachment factors of choice are particularly positive attributes. Favourable responses to 
BMSF have been observed in vitro using all three corneal cell types and preliminary studies 
of biocompatibility have also yielded positive results. Based upon this success to date, pre-
clinical studies of safety and efficacy for corneal cells transplanted on BMSF membranes are 
therefore expected in the near future.  
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